Potential Depression Risk Linked to Ozempic-Like Drugs

Potential Depression Risk Linked to Ozempic-Like Drugs

A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and increased risk of depression and suicidal ideation, especially in people with low dopamine function. Researchers used advanced pharmacogenomic tools to identify genetic pathways that may be vulnerable to dopamine dysregulation when exposed to these medications.

Doctor says "it should be illegal" to prescribe things like Ozempic without mandating strength training and protein requirements.

In a thought-provoking discussion on the Huberman Lab podcast, renowned functional medicine expert Dr. Mark Hyman made a bold statement regarding the increasingly popular GLP-1 agonist medications like Ozempic, suggesting that prescribing these types of things without proper exercise and nutritional guidance is problematic. “I personally think it should be illegal to prescribe these dr*gs unless they’re combined with a nutrition consult to educa…